A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott
Phase 1, Blinded, Randomized, Placebo-controlled Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Main Selection Criteria for Healthy Volunteers:
* Subject has provided written consent.
* Subject is in general good health.
* If female, subject is postmenopausal for at least 2 years or surgically sterile.
* If female, subject is not pregnant and is not breast-feeding.
* Male or female between 18 and 55 years old, inclusive.
* If male, subject must be surgically sterile or practicing at least 1 method of birth control.
* Body Mass Index (BMI) is 18 to 29, inclusive.
You may not be if
Use of medications including over the counter and vitamines.
Abuse of alcohol, drugs, or nicotine.
Current diseases or disorders.
History of cardiac disease.
If after consideration by the investigator, for any reason, that you are unsuitable to receive ABT-072.
